Retatrutide is a novel glucagon-like peptide-1 receptor agonist. This drug has shown promise in controlling type 2 diabetes. By mimicking the actions of naturally occurring GLP-1, Retatrutide enhances insulin secretion https://allenbyhx478532.blog-gold.com/profile